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Use of femoral-femoral veno-arterial (VA) extracorporeal 
membrane oxygenation (ECMO) for cardiopulmonary support 
during lung transplantation can be inadequate for efficient dis-
tribution of oxygenated blood into the coronary circulation. 
We hypothesized that creating a left-to-right shunt flow using 
veno-arterio-venous (VAV) ECMO would alleviate the differ-
ential hypoxia. Total 10 patients undergoing lung transplanta-
tion were enrolled in this study. An additional inflow cannula 
was inserted into the right internal jugular (RIJ) vein for VAV 
ECMO. During left one-lung ventilation using a 1.0 inspired 
oxygen fraction (FiO2), the left-to-right shunt flow was incre-
mentally increased from 0 to 500, 1,000, and 1,500 ml/min. 
The arterial oxygen partial pressure (PaO2) and oxygen satu-
ration (SaO2) were measured at the proximal ascending aorta 
and right radial artery. The ascending aorta gas analysis re-
vealed that six patients had a PaO2/FiO2 ratio less than 200 mm 
Hg at a 0 ml/min shunt flow. The PaO2 (SaO2) values were 
48.5 ± 14.8 mm Hg (80.9 ± 11.6%) at the ascending aorta and 
77.8 ± 69.7 mm Hg (83.3 ± 13.2%) at the right radial artery. As 
the left-to-right shunt flow rate increased over 1,000 ml/min, 
the PaO2 and SaO2 values for the ascending aorta and right ra-
dial artery significantly increased. In conclusion, femoral-fem-
oral VA ECMO can produce suboptimal coronary oxygenation 
in patients unable to tolerate one-lung ventilation. A left-to-
right shunt using VAV ECMO can alleviate the differential hy-
poxia. ASAIO Journal 2020; 66:803–808.
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Veno-veno (VV) and veno-arterial (VA) extracorporeal mem-
brane oxygenation (ECMO) are gaining acceptance as poten-
tially effective options for use in high-mortality situations and 
as tools that can replace the cardiopulmonary bypass (CPB) 
machine and support surgery requiring CPB use.1 Although 
CPB has been the standard technique used for intraoperative 
cardiorespiratory support during lung transplantation (LTX),2 
results of various studies indicate that VA ECMO can be used 
as a substitute for CPB to provide intraoperative hemodynamic 
support during LTX.3–7 Compared with CPB, VA ECMO is more 
versatile and results in better postoperative outcomes.3,6,8
During use of femoral-femoral VA ECMO for the patient with 
respiratory failure accompanied by severe hemodynamic impair-
ment, the patient may develop upper body hypoxemia called 
differential hypoxia.9,10 The application of an additional inflow 
cannula to the RIJ vein to add left-to-right shunt might alleviate 
myocardial depression or cerebral infarct by supplying sufficient 
oxygen.11 Studies performed in the intensive care unit (ICU) set-
ting have revealed the efficacy of providing a left-to-right shunt 
during ECMO support.9,10,12,13 We hypothesized that differential 
hypoxia may occur in patients undergoing LTX using femora-
femoral VA ECMO, and planned to assess the extent of hypox-
emia by sampling the blood at the proximal ascending aorta 
adjacent to the coronary artery. To our knowledge, there have 
been no studies that directly measured oxygenation at the coro-
nary artery level using femoral-femoral VA ECMO in patients who 
require respiratory and hemodynamic support. The objective of 
this study was to evaluate whether creating a left-to-right shunt 
flow using veno-arterio-venous (VAV) ECMO would alleviate the 
differential hypoxia that can occur in patients undergoing LTX.
Materials and Methods
Patients
The protocol for this single-center, prospective clinical trial 
complies with the Declaration of Helsinki and was approved 
by the institutional review board (number: 4-2016-0124) at 
Severance Hospital, Yonsei University Health System, Seoul, 
Republic of Korea. The study was registered at www.clinicaltri-
als.gov (NCT02859194).
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Ten patients scheduled for LTX between May 2016 and Sep-
tember 2016 were consecutively enrolled in the study. Each 
patient provided written informed consent before enrollment. 
Patients greater than or equal to 20 years of age and scheduled 
for an isolated double LTX with ECMO support were consid-
ered eligible. Patients with a history of coronary artery disease 
or any type of arrhythmia were excluded from the trial.
Anesthetic and Study Protocol
Immediately after arrival at the operating theater, right ra-
dial artery cannulation and routine hemodynamic monitoring 
were achieved and followed by insertion of a pulmonary artery 
catheter (Swan-Ganz CCOmbo; Edwards Lifesciences, Irvine, 
CA). No premedication was given to patients. Induction of an-
esthesia was achieved using midazolam (0.5 mg/kg), sufentanil 
(1.0–3.0 µg/kg), and rocuronium bromide (1 mg/kg). Anesthesia 
was maintained using a 0.4–1.5vol% end-tidal concentration 
of sevoflurane and a continuous sufentanil (0.3–0.5 µg/kg/h) 
infusion to achieve a bispectral index score of 40–60. Mechan-
ical ventilation was maintained using a 6 ml/kg tidal volume 
with a 5 mm Hg positive end-expiratory pressure. Respiratory 
frequency was adjusted to maintain an end-tidal carbon di-
oxide concentration approximately 40 mm Hg and an inspired 
oxygen fraction of 1.0 until the ECMO was initiated for the op-
eration. A multiplane transesophageal echocardiography (TEE) 
probe (6TC; GE, Vingmed Ultrasound AS, Horten, Norway) 
was inserted after induction of anesthesia.
Insertion of peripheral VA ECMO was commenced after 
induction of anesthesia. Before initiation of the ECMO can-
nulation, a single, unfractionated heparin bolus targeting an 
activated clotting time between 160 and 180 seconds was 
administered. Veno-arterial ECMO using the Bioline hepa-
rin-coated Quadrox PLS circuit system (Maquet Cardiopul-
monary, Hirrlingen, Germany) primed with 0.8 L acetated 
Ringer’s solution (Plasma Solution A Inj.; CJ Pharma, Seoul, 
Korea) was performed with femoral artery-femoral vein can-
nulation. An arterial cannula (15–17 Fr), which was used for 
the arterial inflow, was inserted into the common femoral ar-
tery via the percutaneous route using the cut-down method, 
followed by cannula (20–24 Fr) insertion into the common 
femoral vein for the venous outflow. Upon switching to VAV 
ECMO, an additional arterial inflow cannula (15–17 Fr) was 
inserted into the RIJ vein. A Y connector was used to connect 
this additional inflow cannula to the existing inflow circuit. 
The venous and additional inflow cannula positions were 
adjusted using TEE guidance. The tip of the femoral vein can-
nula was adjusted between the inferior vena cava and right 
atrial junction. The tip of the additional inflow RIJ vein can-
nula lay approximately at the superior vena cava and the right 
atrium junction. A vascular clamp device and the Novaflow 
c Ultrasonic Flowcomputer (NovaLung GmbH, Heilbronn, 
Germany) were used to regulate inflow to the RIJ vein. Dur-
ing the study period, the FiO
2 of the ECMO was maintained 
at 1.0 and the sweep gas rate was adjusted according to a 
carbon dioxide partial pressure (PaCO2) result from the arte-
rial blood gas analysis (ABGA) of approximately 40 mm Hg. 
A pediatric cardioplegia catheter was placed and fixed at the 
proximal ascending aorta to collect blood samples for gas 
analysis. The samples were used to evaluate coronary artery 
oxygenation.
Surgical exposure was achieved using a clamshell incision, 
and the surgery was performed in right-to-left order. The crys-
talloid solution infusion rate was 6–8 ml/kg/h. Norepinephrine 
and vasopressin were used to maintain mean arterial pressure 
between 60 and 80 mm Hg during the operation. Milrinone 
was administered to patients with pre-existing or newly de-
veloped right ventricular (RV) failure or moderate to severe 
pulmonary hypertension. During the operation, the pulmonary 
artery catheter was withdrawn by approximately 5 cm to pre-
vent interference with anastomosis. Packed red blood cells and 
cell saver salvaged blood were transfused when the hematocrit 
was less than 27%. Use of transfusion of fresh frozen plasma 
and platelets was consistent with institutional guidelines.14
Outcome Assessments
The primary outcome was to evaluate the effect of left-to-right 
shunt on oxygenation during femoral-femoral VA ECMO. Dur-
ing the right lung operation with left one-lung ventilation (OLV), 
ECMO, and ventilatory FiO2 were fixed at 1.0 and the RIJ cannula 
inflow was increased from 0 ml/min to 1,500 ml/min by 500 ml/
min increments, as referenced by previous study9 (0–500, 1,000, 
and 1,500 ml/min). Five minutes after each flow rate increase, 
hemodynamic variables, respiratory variables, and cerebral ox-
ygen saturation (rSO2) were recorded, and blood samples were 
collected from the right radial artery, proximal ascending aorta, 
and pulmonary artery. Arterial oxygen partial pressure (PaO2), 
PaCO2, and oxygen saturation (SaO2) were measured at the right 
radial artery and proximal ascending aorta. Venous oxygen par-
tial pressure and mixed oxygen saturation (SvO2) were measured 
at the pulmonary artery. Hemodynamic variables included heart 
rate, mean arterial pressure, mean pulmonary artery pressure, 
and peripheral oxygen saturation (SpO2) at the right index finger. 
Respiratory variables included the peak airway pressure. During 
the experimental periods, total ECMO flow was maintained at 
approximately 60 ml/kg/min. After the study protocol was com-
pleted, additional inflow rate was maintained at 500 ml/min 
until the end of the operation.
Statistical Analysis
The data were collected from ten consecutively enrolled 
patients. Results for the baseline characteristics of the study par-
ticipants were presented as mean ± standard deviation values for 
continuous variables; frequencies (percentages) were used for cat-
egorical variables. The Student’s t-test or paired t-test was used for 
analysis of continuous variables and χ2 or Fisher’s exact test for 
categorical variables, as appropriate. SPSS software (Version 23.0; 
SPSS Inc., Chicago, IL) was used for all statistical analysis and p 
values of less than 0.05 were considered statistically significant.
Results
Individual data points of PaO2 of proximal ascending aorta at 
baseline, 500 ml/min, 1,000 ml/min, and 1,500 ml/min of addi-
tional flow were connected and demonstrated by a line graph 
(Figure 1). The groups were divided by a single straight line 
graphed by the regression model of each data point, which met 
the baseline at the point of P/F ratio of 180 mm Hg. This was 
cross-checked by k-means cluster analysis, and the results of 
calculated average of the two groups at baseline were 48.5 mm 
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Hg and 359.8 mm Hg, respectively. The result average of the 
two groups was 204.2 mm Hg. Accordingly, the data were ana-
lyzed using a ratio of partial pressure of arterial oxygen to the 
fraction of inspired oxygen (P/F ratio) less than 200 group and 
a P/F ratio greater than or equal to 200 group.
The results indicated that except for pulmonary function, 
the demographic variables were comparable between the two 
groups (Table 1). The results for the hemodynamic variables 
and peak airway pressure after an increase to additional ECMO 
flow indicated that there were no significant between-group 
differences (Table 2).
In the P/F ratio less than 200 group, the mean SpO2 was 81% with 
no shunt flow but increased to 96%, 97%, and 99%, respectively, 
with the incremental increase in shunt flow from 500 to 1,500 ml/
min (Table 3). The only statistically significant difference in SpO2 
occurred at the 1,500 ml/min shunt flow rate. Cerebral oxygen sat-
uration was comparable between different shunt flow rates. After 
the left-to-right shunt flow rate was increased to 1,000 ml/min and 
1,500 ml/min, PaO2 and SaO2 from the ascending aorta, and radial 
artery were significantly increased, compared with no shunt flow. 
After a shunt flow rate increase to 500 ml/min, between-group dif-
ferences in pulmonary artery oxygen partial pressure and mixed 
venous oxygen saturation were statistically significant, compared 
with no shunt flow. At 1,500 ml/min shunt flow, the p values for 
PaO2 from the ascending aorta and the radial artery, and for the 
SvO2, were more statistically significant (p = 0.004, 0.007, and 
0.008, respectively) than the p values at a 1,000 ml/min shunt flow 
(p = 0.046, 0.040, and 0.018, respectively).
Four patients with a P/F ratio greater than or equal to 200 
had no significant differences in SpO2, rSO2, oxygen partial 
pressure (PO2), and SO2 from the proximal aorta, radial artery, 
and pulmonary artery.
Discussion
This study was the first to directly measure the oxygenation 
level near the coronary circulation during femoral-femoral VA 
ECMO using femoral artery-femoral vein cannulation during 
LTX. The study revealed that femoral-femoral VA ECMO may 
produce suboptimal coronary oxygenation in patients who are 
unable to tolerate OLV. A small left-to-right shunt using VAV 
ECMO can prevent differential hypoxia and maintain coronary 
and cerebral oxygenation.
Extracorporeal membrane oxygenation use is associated 
with lower heparin doses and reduced blood activating surface 
due to lack of a venous reservoir and additional suction lines.3 
Thus, compared with CPB, coagulopathy, and inflammatory 
cascades are attenuated when ECMO is used. Extracorporeal 
Figure 1. Changes of arterial oxygen partial pressure (PaO2) at 
the proximal aorta according to the changes of additional inflow. 
A single dotted line was graphed by using the regression model of 
each data point.
Table 1.  Patients’ Characteristics
All Patients 
(n = 10)
P/F Ratio < 200 
(n = 6)
P/F Ratio ≥ 200 
(n = 4)
Age (years) 54.7 ± 9.5 53.3 ± 12.0 56.8 ± 4.6
Sex (male/female), n (%) 7/3 5/1 2/2
Body surface area (m2) 1.64 ± 0.19 1.63 ± 0.20 1.66 ± 0.21
Height (cm) 165.2 ± 7.7 167.2 ± 6.5 162.3 ± 9.3
Weight (kg) 59.0 ± 11.9 57.5 ± 12.6 61.4 ± 12.1
Results of transthoracic echocardiography
  Ejection fraction (%) 62.7 ± 5.5 63.3 ± 6.1 61.8 ± 5.0
  E/E′ 9.2 ± 2.7 8.7 ± 2.3 10.0 ± 3.6
  Right ventricular systolic pressure 47.4 ± 17.3 52.8 ± 14.9 39.3 ± 19.4
Type of disease
  Idiopathic pulmonary fibrosis 8 5 3
  ARDS 1 1  
  COPD 1  1
Preoperative pulmonary function test
  FVC (L) 1.50 ± 0.44 1.66 ± 0.46 1.31 ± 0.38
  FVC (%, predicted) 41.1 ± 8.0 44.6 ± 9.3 37 ± 3.3
  FEV1 (L) 1.23 ± 0.51 1.52 ± 0.41 0.86 ± 0.37
  FEV1 (%, predicted) 46.3 ± 17.1 56.6 ± 13.5 33.5 ± 11.8*
  FEV1/FVC ratio (%) 81.7 ± 20.2 92.0 ± 3.1 68.8 ± 25.9*
  DLCO (%, predicted) 28.3 ± 9.5 25.8 ± 7.9 33.5 ± 13.4
Values are expressed as the numbers of patients with percentage, mean ± SD. *p < 0.05 compared to P/F ratio < 200 group.
ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; DLCO, diffusion capacity of lung for carbon 
monoxide; E/E', peak early diastolic transmitral inflow velocity (E) / peak early diastolic mitral annular velocity (E');  FEV1, forced expiratory 
volume in one second; FVC, forced vital capacity; SD, standard deviation.
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membrane oxygenation use can easily be extended to post-
operative care (i.e., during postoperative graft dysfunction).3 
Because these advantages result in better outcomes,8 some 
European and North American centers changed their primary 
intraoperative cardiopulmonary support technique from CPB 
to ECMO.3–7 Since 2013, our institution has performed LTX 
using the peripheral ECMO technique.15
Peripheral VA ECMO, especially femoral-femoral VA ECMO, 
does not always guarantee oxygenation of distal organs. The 
blood coming from the ECMO meets the blood coming from 
the left ventricle from the opposite direction; they combine in 
a “mixing zone.”16,17 The left ventricular blood oxygen con-
tent is unknown, which presents a risk of profound heart and 
brain hypoxemia when the mixing zone is located distal to 
the carotid arteries. Some animal studies have found that use 
of peripherally cannulated ECMO systems results in adequate 
cerebral and coronary tissue oxygenation.18 However, clin-
ical studies have found that patients experience stroke and 
post apoplectic intracerebral bleeding or severe myocardial 
necrosis.19 In addition, hypoxia causes acute hypoxic pulmo-
nary vasoconstriction of small muscular pulmonary arteries20 
and substantially increases pulmonary vascular resistance, 
Table 2.  Results of Hemodynamic Variables and Peak Airway Pressure After Increase of Additional ECMO Flow
Left-to-Right Shunt Flow
Additional ECMO Flow Through Right Internal Jugular Vein
0 ml/min 500 ml/min 1,000 ml/min 1,500 ml/min
P/F ratio < 200
  Heart rate 110 ± 6 111 ± 6 109 ± 10 114 ± 7
  Mean arterial pressure 83 ± 8 75 ± 8 73 ± 12 74 ± 8
  Mean pulmonary artery pressure 23 ± 4 21 ± 6 27 ± 8 29 ± 11
  Cardiac index 3.2 ± 0.2 3.0 ± 0.4 2.8 ± 0.6 2.7 ± 0.6
  Peak airway pressure 38 ± 6 32 ± 8 36 ± 7 36 ± 6
P/F ratio ≥ 200
  Heart rate 90 ± 12 88 ± 11 89 ± 11 92 ± 14
  Mean arterial pressure 91 ± 24 77 ± 28 71 ± 13 75 ± 14
  Mean pulmonary artery pressure 11 ± 6 13 ± 0 14 ± 3 16 ± 6
  Cardiac index 2.5 ± 0.5 2.6 ± 0.6 2.6 ± 0.6 2.8 ± 0.7
  Peak airway pressure 33 ± 7 36 ± 9 37 ± 8 36 ± 6
Values are expressed as mean ± SD.
ECMO, extracorporeal membrane oxygenation; SD, standard deviation.
Table 3.  Comparison of Oxygenation at Each Site With Increasing Left-to-Right Shunt Flow Using VAV ECMO
Left-to-Right Shunt Flow
Additional ECMO Flow Through Right Internal Jugular Vein
0 ml/min 500 ml/min 1,000 ml/min 1,500 ml/min
P/F ratio < 200
  SpO2 81 ± 18 96 ± 4 97 ± 4 99 ± 3*
  rSO2 (left) 47 ± 13 51 ± 7 46 ± 6 46 ± 8
  rSO2 (right) 39 ± 13 45 ± 11 40 ± 7 41 ± 5
  PO2
   Aorta 48.5 ± 14.8 78.0 ± 39.3 236.2 ± 178.9* 216.7 ± 94.2*
   Radial artery 77.8 ± 69.7 93.7 ± 54.5 149.5 ± 121.5* 242.4 ± 112.4*
   Pulmonary artery 37.6 ± 4.5 50.2 ± 5.7* 57.4 ± 5.3* 66.5 ± 10.9*
  SO2
   Aorta (%) 80.9 ± 11.6 93.0 ± 5.8 97.7 ± 3.8* 99.1 ± 1.2*
   Radial (%) 83.3 ± 13.2 94.9 ± 3.6 96.9 ± 3.1* 99.1 ± 1.3*
   SvO2 (%) 72.4 ± 7.3 85.1 ± 3.6* 88.7 ± 4.0* 92.5 ± 2.4*
P/F ratio ≥ 200
  SpO2 99.8 ± 0.5 98.8 ± 2.5 99 ± 2 99.8 ± 0.5
  rSO2 (left) 50 ± 5 50 ± 5 45 ± 7 44 ± 11
  rSO2 (right) 54 ± 11 49 ± 11 43 ± 8 39 ± 3
  PO2
   Aorta 359.8 ± 49.6 391.0 ± 25.0 419.1 ± 33.8 416 ± 52
   Radial artery 370.1 ± 65.8 419.6 ± 28.8 398.9 ± 44.0 433.7 ± 36.9
   Pulmonary artery 46.2 ± 8.6 68.6 ± 21.3 84.8 ± 28.6 94.2 ± 23.3
  SO2
   Aorta (%) 99.9 99.9 99.9 99.9
   Radial (%) 99.9 99.9 99.9 99.9
   SvO2 (%) 82.7 ± 14.1 921 ± 4.1 94.6 ± 4.9 95.8 ± 2.1
Values are expressed as mean ± SD.
*p < 0.05 compared with the value of 0 ml/min shunt flow.
ECMO, extracorporeal membrane oxygenation; P/F, ratio of arterial oxygen partial pressure to inspired oxygen fraction; PO2, oxygen partial 
pressure; rSO2, cerebral oxygen saturation; SD, standard deviation; SO2, oxygen saturation; SpO2, peripheral oxygen saturation; SvO2, mixed 
venous oxygen saturation; VAV, veno-arterio-venous.
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eventually contributing to increased RV afterload.21 For these 
reasons, femoral-femoral VA ECMO may not sufficiently mit-
igate the pre-existing burden of RV dysfunction if hypoxia 
persists, which may make difficult to wean from ECMO after 
surgery.
There have been some studies of alleviation of the differen-
tial hypoxia resulting from VA ECMO in the ICU setting. Stöhr 
et al.13 found that in patients undergoing ECMO therapy for 
acute respiratory distress syndrome, converting to VAV ECMO 
from VV or VA modality conferred a survival benefit com-
pared with the VV and VA ECMO configurations. The study by 
Moravec et al.12 revealed that two patients with cerebral hypox-
emia under VA ECMO circumstances were successfully treated 
after changing to VAV ECMO. Veno-arterio-venous ECMO can 
be a hybrid ECMO that can overcome the shortcomings of VV 
ECMO and VA ECMO.
Consistent with the results of animal22,23 and clinical stud-
ies,9,13 we found that the VAV ECMO-associated left-to-right 
shunt provided sufficient oxygenation in a less invasive and 
relatively safe manner in patients with a P/F ratio less than 200 
who did not tolerate OLV during femoral-femoral VA ECMO. 
This can be considered as a way of inducing the redistribution 
of oxygen delivery rather than increasing the amount of oxygen 
since the total flow remains the same. Unlike the findings by 
Ius et al.9, we found that a minimal flow of 1,000 ml/min pro-
vided sufficient oxygenation through RIJ catheter inflow. This 
result was consistent with the findings by Moravec et al.12 that 
indicated that a flow of 1,200 ml/min through the additional 
inflow catheter provides sufficient oxygen during VAV ECMO 
in patients who cannot tolerate the VA or VV ECMO modali-
ties. They recommended using a large-bore catheter (≥ 16 Fr) 
to maintain greater than or equal to 1,500 ml/min of additional 
flow in patients who require a high cardiac output through the 
VAV ECMO. However, if enough oxygen is supplied at a flow 
rate of 1,000 ml/min as in our study, it should be reconsid-
ered whether these recommendations are necessary. The risk of 
hemorrhage is a disadvantage of VAV ECMO,9,11,24 but we have 
found little difference between results using VAV ECMO and 
our previous experience with VA ECMO techniques.15
The reason why the rSO2 was well maintained, despite low 
oxygen levels in proximal aorta, is presumably since the mix-
ing zone was located between the proximal part of head ves-
sels and coronary artery ostium. This suggests that cerebral 
oxygenation is relatively well preserved in femoral-femoral VA 
ECMO. This also indicates that it is not accurate to predict the 
SaO2 of coronary artery by monitoring rSO2 or ABGA of the 
right hand in patients receiving LTX under femoral-femoral VA 
ECMO. As shown in our study results, the mean PaO2 of radial 
artery was 77.8 mm Hg, but the average PaO2 of aorta level 
was only 48.5 mm Hg in P/F ratio less than 200 group when 
the left-to-right shunt flow was 0 ml/min. Therefore, even if the 
PaO2 of the radial artery under VA ECMO is measured upper 
normal value, coronary oxygenation could be inadequate if a 
“watershed” is formed between the coronary artery ostium and 
the supra-aortic branches of the ascending aorta. There are few 
methods available to directly assess coronary artery oxygena-
tion; similar to the case report by Hoeper et al.25, only the TEE 
can be considered as a tool to assess cardiac function.
The differential hypoxia associated with peripheral VA 
ECMO might not occur during central VA ECMO. The central 
ECMO cannulation technique is structurally similar to CPB, so 
all organs can receive sufficient oxygenation. It also reduces 
groin wound complications and peripheral vascular problems. 
However, during LTX, central ECMO has some limitations. The 
drainage catheter at right atrium can interfere with the surgical 
field, hinder efficient operation. Furthermore, donor lung can 
be exposed to prolonged ischemia due to delays in the tho-
racic surgery steps, which are performed after initiation of cen-
tral ECMO. In addition, central VA ECMO can make it difficult 
to maintain ECMO after surgery. In contrast, the peripherally 
inserted VA ECMO can reduce the ischemia and operation 
time and is easier to convert to postoperative ECMO support to 
manage primary graft dysfunction.
This study had several limitations. Although we showed that 
femoral-femoral VA ECMO may cause insufficient oxygenation 
in the cerebral or coronary circulation, we were not able to elu-
cidate the cause of failure OLV or differential hypoxia. Preop-
erative lung function and cardiac function variables were not 
significantly different between those groups, except for forced 
expiratory volume in one second (FEV1) and FEV1/forced vital 
capacity ratio. The pathophysiologic changes that were caused 
by OLV (e.g., intrapulmonary shunt changes or hypoxic pulmo-
nary vasoconstriction) seem to be more relevant for explaining 
the differential hypoxia, compared with the results of the var-
ious preoperative examinations. Second, because the objective 
of this study was to identify the level of oxygenation near the 
coronary circulation and the effect of left-to-right shunt during 
LTX with VA ECMO, no follow-up and comparison was per-
formed to evaluate postoperative heart function and graft func-
tion. Further investigation is warranted to compare the overall 
cardiac function before and after surgery to confirm the out-
comes of VAV ECMO-provided left-to-right shunt.
In conclusion, our study revealed the presence of suboptimal 
coronary oxygenation using a peripheral VA ECMO applica-
tion in patients unable to tolerate OLV during LTX. We suggest 
that creating a small left-to-right shunt using VAV ECMO is a 
valid method for intraoperative support of hemodynamics and 
respiratory function during LTX; this method prevents the dif-
ferential hypoxia resulting from peripheral VA ECMO.
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